Andrew Dickinson

Executive Vice President, Corporate Development and Strategy

Gilead

Andrew Dickinson joined Gilead in 2016 and is responsible for overseeing the company’s corporate development, alliance management, competitive intelligence, and corporate strategy and planning groups. He helped engineer the company’s 2017 acquisition of Kite Pharma Inc. Prior to joining Gilead, he served as Global Co-Head of Healthcare Investment Banking for Lazard. At Lazard, he advised on numerous, industry-defining merger and acquisition transactions, as well as many other strategic matters across the biopharmaceutical industry. He received his bachelor’s degree in molecular, cellular and developmental biology from the University of Colorado and his law degree from Loyola University Chicago.